[Conclusions. Tenofovir]

Enferm Infecc Microbiol Clin. 2008 Jun:26 Suppl 8:62-4. doi: 10.1157/13126273.
[Article in Spanish]
No abstract available

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / pharmacokinetics
  • Adenine / therapeutic use
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / pharmacokinetics
  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Viral / genetics
  • HIV / enzymology
  • HIV / genetics
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Reverse Transcriptase / genetics
  • Humans
  • Kidney Diseases / complications
  • Liver Diseases / complications
  • Organophosphonates / adverse effects
  • Organophosphonates / pharmacokinetics
  • Organophosphonates / therapeutic use*
  • Reverse Transcriptase Inhibitors / adverse effects
  • Reverse Transcriptase Inhibitors / pharmacokinetics
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Tenofovir
  • HIV Reverse Transcriptase
  • Adenine